- Previous Close
3,255.70 - Open
3,318.95 - Bid --
- Ask --
- Day's Range
3,021.05 - 3,376.00 - 52 Week Range
1,943.70 - 3,653.95 - Volume
1,232,956 - Avg. Volume
215,197 - Market Cap (intraday)
253.979B - Beta (5Y Monthly) 0.30
- PE Ratio (TTM)
63.29 - EPS (TTM)
48.18 - Earnings Date Oct 23, 2024
- Forward Dividend & Yield 30.00 (0.92%)
- Ex-Dividend Date Aug 20, 2024
- 1y Target Est
998.00
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.
www.lalpathlabs.com4,099
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: LALPATHLAB.NS
View MorePerformance Overview: LALPATHLAB.NS
Trailing total returns as of 10/24/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LALPATHLAB.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LALPATHLAB.NS
View MoreValuation Measures
Market Cap
271.19B
Enterprise Value
261.57B
Trailing P/E
67.49
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
11.56
Price/Book (mrq)
13.55
Enterprise Value/Revenue
11.72
Enterprise Value/EBITDA
37.85
Financial Highlights
Profitability and Income Statement
Profit Margin
17.11%
Return on Assets (ttm)
12.83%
Return on Equity (ttm)
21.17%
Revenue (ttm)
23.46B
Net Income Avi to Common (ttm)
4.01B
Diluted EPS (ttm)
48.18
Balance Sheet and Cash Flow
Total Cash (mrq)
11.27B
Total Debt/Equity (mrq)
9.75%
Levered Free Cash Flow (ttm)
4.34B
Research Analysis: LALPATHLAB.NS
View MoreCompany Insights: LALPATHLAB.NS
LALPATHLAB.NS does not have Company Insights